
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 20.030 | 22.570 | 2.540 |
Shares | 79.980 | 84.770 | 4.790 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 3.923 | 19.570 |
Price to Book | 1.142 | 3.777 |
Price to Sales | 0.566 | 2.182 |
Price to Cash Flow | 7.524 | 14.572 |
Dividend Yield | 1.835 | 1.490 |
5 Years Earnings Growth | 6.293 | 9.859 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 78.160 | 94.890 |
Financial Services | 8.360 | 7.256 |
Industrials | 5.560 | 2.752 |
Consumer Cyclical | 4.530 | 7.019 |
Consumer Defensive | 3.380 | 3.041 |
Number of long holdings: 39
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Georgia Capital | GB00BF4HYV08 | 7.09 | 2,350.00 | -3.69% | |
Medios AG | DE000A1MMCC8 | 5.56 | 12.8200 | -4.33% | |
AGFA Gevaert | BE0003755692 | 4.72 | 0.83 | -2.36% | |
Fresenius SE | DE0005785604 | 4.64 | 47.640 | +0.91% | |
Eurofins Scientific | FR0014000MR3 | 4.52 | 62.52 | -1.51% | |
STRATEC Biomedical | DE000STRA555 | 4.41 | 27.300 | -0.91% | |
Integrated Diagnostics | JE00BLKGSR75 | 4.29 | 0.54 | 0.00% | |
Fagron | BE0003874915 | 4.17 | 20.65 | +0.24% | |
CIR old | IT0000070786 | 3.84 | 0.6530 | -1.21% | |
Dermapharm | DE000A2GS5D8 | 3.59 | 32.90 | +0.77% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ACATIS Fair Value Modulor Vermogeni | 260.62M | 0.18 | 1.94 | 4.66 | ||
ACATIS Fair Value Modulor Vermogens | 260.62M | 0.68 | 2.62 | 5.26 | ||
FU Fonds Multi Asset Fonds P | 105.03M | 1.61 | 6.96 | 7.75 | ||
HA Aktien Small Cap EMU B | 85.27M | 16.00 | 8.78 | 6.95 | ||
H A Aktien Small Cap EMU A | 85.27M | 13.92 | 15.20 | 7.24 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review